Takeda Pharmaceutical Company Limited
Heterocyclic compound and use thereof

Last updated:

Abstract:

The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity. A compound represented by the formula (I): ##STR00001## wherein each symbol is as described in the specification, or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.

Status:
Grant
Type:

Utility

Filling date:

30 Jan 2020

Issue date:

8 Jun 2021